These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16180943)

  • 1. Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.
    Diamanti-Kandarakis E; Konstantinopoulos PA; Papailiou J; Kandarakis SA; Andreopoulos A; Sykiotis GP
    Sports Med; 2005; 35(10):831-40. PubMed ID: 16180943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of EPO gene doping in blood.
    Neuberger EW; Jurkiewicz M; Moser DA; Simon P
    Drug Test Anal; 2012 Nov; 4(11):859-69. PubMed ID: 22508654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant erythropoietin and analogues: a challenge for doping control.
    Pascual JA; Belalcazar V; de Bolos C; Gutiérrez R; Llop E; Segura J
    Ther Drug Monit; 2004 Apr; 26(2):175-9. PubMed ID: 15228161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent advances in the detection of recombinant human erythropoiesis and its analogs in doping control].
    Yang X; Pang N; Liao Y; Liu H
    Se Pu; 2008 Jul; 26(4):413-6. PubMed ID: 18959234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procedures for monitoring recombinant erythropoietin and analogues in doping control.
    Segura J; Pascual JA; Gutiérrez-Gallego R
    Anal Bioanal Chem; 2007 Aug; 388(7):1521-9. PubMed ID: 17516052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in the detection of human erythropoietin and human growth hormone doping].
    Guo L; Zhang Z; Tang J; Xie J
    Se Pu; 2008 Jul; 26(4):437-43. PubMed ID: 18959238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse.
    Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J
    Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin and blood doping.
    Robinson N; Giraud S; Saudan C; Baume N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i30-4. PubMed ID: 16799100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oxygen blood transport and doping].
    Audran M; Connes P; Varlet-Marie E
    Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for rhEPO detection in sport.
    Kazlauskas R; Howe C; Trout G
    Clin J Sport Med; 2002 Jul; 12(4):229-35. PubMed ID: 12131056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
    Schumacher YO; Saugy M; Pottgiesser T; Robinson N
    Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrative 'omics' solution to the detection of recombinant human erythropoietin and blood doping.
    Pitsiladis YP; Durussel J; Rabin O
    Br J Sports Med; 2014 May; 48(10):856-61. PubMed ID: 24627340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doping in the recombinant era: strategies and counterstrategies.
    Azzazy HM; Mansour MM; Christenson RH
    Clin Biochem; 2005 Nov; 38(11):959-65. PubMed ID: 16286094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPO use by Brazilian athletes since 2000.
    Almeida CB; Rodrigues DN; Barros EC
    Subst Use Misuse; 2014 Jul; 49(9):1126-31. PubMed ID: 24832719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin test methods.
    Breymann C
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Mar; 14(1):135-45. PubMed ID: 10932816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels.
    Kohler M; Ayotte C; Desharnais P; Flenker U; Lüdke S; Thevis M; Völker-Schänzer E; Schänzer W
    Int J Sports Med; 2008 Jan; 29(1):1-6. PubMed ID: 18050057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.